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Inﬂuenza H1N1 or A virus is a new virus serotype capable of human-to-human transmission. This infection causes a ﬂu syndrome
similar to that of seasonal inﬂuenza, with only one case of conjunctivitis described and no clinical details or microbiological
conﬁrmation. Its diagnosis is performed by PCR of pharyngeal smear of the patients aﬀected. We report the ﬁrst well-documented
case in the medical literature of conjunctivitis by H1N1 virus.
1.CaseReport
A 45-year-old woman, ﬁve days after diagnosis by pha-
ryngeal smear of inﬂuenza H1N1, complained of an acute
unilateral conjunctivitis condition of bleeding appearance.
Her examination evidenced signiﬁcant eyelid oedema, severe
mixed conjunctival hyperaemia and moderate chemosis, and
pseudomembrane formation. A large number of subtarsal
follicles and petechiae were seen (Figures 1, 2, 3,a n d4).
A smear of conjunctival secretion from both eyes and
study by PCR of H1N1 virus were performed detecting the
presence of H1N1 virus RNA only in the aﬀected eye, being
negative in the contralateral.
After 15 days of symptomatic treatment with topical
NSAIDs and washes associated with topical ganciclovir, the
condition subsided.
2. Discussion
In April 2009, the US CDC identiﬁed the organism responsi-
ble for the new worldwide inﬂuenza pandemic, the inﬂuenza
A virus (H1N1),arising from the gene mutation of segments
of two strains of an inﬂuenza virus present in swine [1].
The clinical symptoms caused by this new inﬂuenza
virus are similar to those of seasonal human inﬂuenza,
including high fever, cough, sore throat, generalised myalgia,
headache, and asthenia, often associated with vomiting
and diarrhoea. Only one case of conjunctivitis has been
mentioned associated with this syndrome. Nevertheless, no
informationaboutitspresentation,course,andoutcomeand
no microbiological prove are available [2]. The CDC has
developed a speciﬁc panel of real-time reverse transcriptase
polymerase chain reaction (r-RT-PCR) for the speciﬁc
microbiological diagnosis of the new inﬂuenza virus strain
[3].
Although multiple complications have been described
in association with infection by this virus, to date no
microbiologically proven cases of conjunctivitis by H1N1
virus have been published.
Viral conjunctivitis in adults is generally caused by an
adenovirus, with over 50 serotypes and a high suscepti-
bility to cause epidemics. Its most characteristic clinical
signs are those discussed in our case [4]. The presence
of ipsilateral preauricular adenopathy, subtarsal follicles
and subconjunctival bleeding, chemosis, and formation of
pseudomembranes is characteristic in severe cases. There2 Journal of Ophthalmology
Figure 1: Lower chemosis and severe conjunctival hyperaemia,
associated with signiﬁcant eyelid oedema in both eyes.
Figure 2: Lower chemosis and severe conjunctival hyperaemia,
associated with signiﬁcant eyelid oedema in both eyes.
are no speciﬁc authorised antivirals for the treatment of
conjunctivitis.
In the case of our patient, it was shown how the onset of
the conjunctival infection, its clinical outcome, its duration
of three weeks, and the characteristics of the eye exami-
nation would be virtually identical to those of adenoviral
conjunctivitis, except for the absence of preauricular node.
This should lead us to consider the diﬀerential diagnosis of
conjunctivitis by the H1N1 virus in patients with consistent
inﬂuenza conditions, all the more given the worldwide
pandemic caused by this virus which now besets us.
Inourcase,theclinicaloutcomeoftheinfectionhasbeen
favourable, with no serious complications, and improving
since the start of treatment, probably due to both the
antiviral eﬀect of topical ganciclovir and the natural course
of the disease. She did not need treatment for her systemic
infection. However, more cases should be described to
evaluate the severity of the conjunctival infection by this new
virus and the possible associated consequences.
Figure 3: Presence of petechiae and signiﬁcant upper subtarsal
follicles.
Figure 4: Inﬂammatory pseudomembranes characteristic of viral
conjunctivitis.
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